Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-7,600
Closed -$552K – 913
2022
Q4
$552K Buy
+7,600
New +$517K ﹤0.01% 797
2022
Q1
– Hold
0
– – – 276
2021
Q3
– Sell
-38,150
Closed -$4.4M – 895
2021
Q2
$4.4M Sell
38,150
-6,000
-14% -$661K 0.03% 429
2021
Q1
$4.06M Hold
44,150
– – 0.03% 408
2020
Q4
$4.23M Sell
44,150
-164,550
-79% -$14.8M 0.03% 419
2020
Q3
$19M Sell
208,700
-24,200
-10% -$2.28M 0.18% 141
2020
Q2
$20M Sell
232,900
-31,725
-12% -$2.39M 0.21% 121
2020
Q1
$15.9M Hold
264,625
– – 0.18% 134
2019
Q4
$16.2M Buy
264,625
+216,135
+446% +$12.7M 0.17% 134
2019
Q3
$2.58M Buy
48,490
+10,090
+26% +$513K 0.03% 449
2019
Q2
$1.96M Buy
+38,400
New +$2.04M 0.02% 522
2018
Q2
– Sell
-10,900
Closed -$611K – 817
2018
Q1
$611K Hold
10,900
– – 0.01% 649
2017
Q4
$752K Hold
10,900
– – 0.01% 627
2017
Q3
$575K Buy
10,900
+3,400
+45% +$195K 0.01% 643
2017
Q2
$451K Hold
7,500
– – 0.01% 666
2017
Q1
$426K Hold
7,500
– – 0.01% 655
2016
Q4
$323K Hold
7,500
– – 0.01% 639
2016
Q3
$361K Buy
7,500
+750
+11% +$31.9K 0.01% 619
2016
Q2
$261K Sell
6,750
-10,000
-60% -$311K 0.01% 630
2016
Q1
$478K Buy
+16,750
New +$502K 0.01% 559

Other funds holding NTES

Candriam SCA's NTES Position: Q1 2023 in Review

Candriam SCA sold out of NetEase (NTES) in Q1 2023, closing a stake of 7,600 shares — an estimated $552K sold.

Candriam SCA first reported a position in NTES in Q1 2016 and held it in 19 quarters. The position peaked at $20M in Q2 2020. 312 funds tracked by Wall St. Rank hold NTES as of Q1 2023.

  • Candriam SCA reported no remaining NetEase position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 7,600 NetEase shares in Q1 2023, an estimated $552K.
  • Candriam SCA first reported a position in NetEase in Q1 2016 and held it in 19 quarters.
  • Candriam SCA's NetEase position peaked at $20M in Q2 2020.
  • 312 funds tracked by Wall St. Rank held NetEase as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.